ZA968783B - Flupirtine usage - Google Patents
Flupirtine usageInfo
- Publication number
- ZA968783B ZA968783B ZA968783A ZA968783A ZA968783B ZA 968783 B ZA968783 B ZA 968783B ZA 968783 A ZA968783 A ZA 968783A ZA 968783 A ZA968783 A ZA 968783A ZA 968783 B ZA968783 B ZA 968783B
- Authority
- ZA
- South Africa
- Prior art keywords
- flupirtine
- usage
- patients
- prophylaxis
- impairment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polyurethanes Or Polyureas (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541405A DE19541405A1 (de) | 1995-11-07 | 1995-11-07 | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA968783B true ZA968783B (en) | 1997-05-27 |
Family
ID=7776799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA968783A ZA968783B (en) | 1995-11-07 | 1996-10-18 | Flupirtine usage |
Country Status (27)
Country | Link |
---|---|
US (2) | US6034111A (pl) |
EP (1) | EP0859613B1 (pl) |
JP (1) | JPH11514652A (pl) |
KR (1) | KR100512673B1 (pl) |
CN (1) | CN1116037C (pl) |
AT (1) | ATE316789T1 (pl) |
AU (1) | AU711207B2 (pl) |
BG (1) | BG63149B1 (pl) |
BR (1) | BR9611588A (pl) |
CA (1) | CA2189705C (pl) |
CZ (1) | CZ298115B6 (pl) |
DE (2) | DE19541405A1 (pl) |
DK (1) | DK0859613T3 (pl) |
ES (1) | ES2257755T3 (pl) |
HK (1) | HK1016508A1 (pl) |
HU (1) | HU225742B1 (pl) |
MX (1) | MX9803610A (pl) |
NO (1) | NO315074B1 (pl) |
NZ (1) | NZ330414A (pl) |
PL (1) | PL186537B1 (pl) |
PT (1) | PT859613E (pl) |
RU (1) | RU2200555C2 (pl) |
SK (1) | SK284601B6 (pl) |
TW (1) | TW393317B (pl) |
UA (1) | UA51682C2 (pl) |
WO (1) | WO1997017072A2 (pl) |
ZA (1) | ZA968783B (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19625582A1 (de) * | 1996-06-27 | 1998-01-02 | Asta Medica Ag | Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen |
US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
DE10327674A1 (de) | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
EP1688141A1 (en) * | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
DE102009023162B4 (de) * | 2009-05-29 | 2011-07-07 | Corden PharmaChem GmbH, 68305 | Verfahren zur Herstellung von Flupirtin |
KR101704849B1 (ko) * | 2009-08-07 | 2017-02-08 | 스와겔로크 컴패니 | 저진공 하에서의 저온 침탄 |
DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
MX2014010460A (es) * | 2012-03-02 | 2014-10-13 | Meda Pharma Gmbh & Co Kg | Formulaciones farmaceuticas que contienen flupirtina. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN172468B (pl) * | 1990-07-14 | 1993-08-14 | Asta Medica Ag | |
DE4327516A1 (de) * | 1993-08-17 | 1995-02-23 | Asta Medica Ag | Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin |
-
1995
- 1995-11-07 DE DE19541405A patent/DE19541405A1/de not_active Ceased
-
1996
- 1996-10-18 ZA ZA968783A patent/ZA968783B/xx unknown
- 1996-10-23 AU AU17165/97A patent/AU711207B2/en not_active Ceased
- 1996-10-23 NZ NZ330414A patent/NZ330414A/en unknown
- 1996-10-23 EP EP96945822A patent/EP0859613B1/de not_active Expired - Lifetime
- 1996-10-23 JP JP9517734A patent/JPH11514652A/ja active Pending
- 1996-10-23 DE DE59611327T patent/DE59611327D1/de not_active Expired - Lifetime
- 1996-10-23 PL PL96326629A patent/PL186537B1/pl not_active IP Right Cessation
- 1996-10-23 AT AT96945822T patent/ATE316789T1/de active
- 1996-10-23 BR BR9611588A patent/BR9611588A/pt not_active Application Discontinuation
- 1996-10-23 SK SK586-98A patent/SK284601B6/sk not_active IP Right Cessation
- 1996-10-23 RU RU98111152/14A patent/RU2200555C2/ru not_active IP Right Cessation
- 1996-10-23 WO PCT/DE1996/002009 patent/WO1997017072A2/de active IP Right Grant
- 1996-10-23 HU HU9901659A patent/HU225742B1/hu not_active IP Right Cessation
- 1996-10-23 UA UA98062946A patent/UA51682C2/uk unknown
- 1996-10-23 CN CN96198131A patent/CN1116037C/zh not_active Expired - Fee Related
- 1996-10-23 CZ CZ0128398A patent/CZ298115B6/cs not_active IP Right Cessation
- 1996-10-23 KR KR10-1998-0703376A patent/KR100512673B1/ko not_active IP Right Cessation
- 1996-10-23 DK DK96945822T patent/DK0859613T3/da active
- 1996-10-23 ES ES96945822T patent/ES2257755T3/es not_active Expired - Lifetime
- 1996-10-23 PT PT96945822T patent/PT859613E/pt unknown
- 1996-11-04 TW TW085113437A patent/TW393317B/zh not_active IP Right Cessation
- 1996-11-06 CA CA002189705A patent/CA2189705C/en not_active Expired - Fee Related
- 1996-11-07 US US08/744,953 patent/US6034111A/en not_active Expired - Lifetime
-
1998
- 1998-04-16 US US09/061,099 patent/US6034112A/en not_active Expired - Lifetime
- 1998-04-24 BG BG102404A patent/BG63149B1/bg unknown
- 1998-04-27 NO NO19981898A patent/NO315074B1/no not_active IP Right Cessation
- 1998-05-07 MX MX9803610A patent/MX9803610A/es not_active IP Right Cessation
-
1999
- 1999-04-21 HK HK99101726A patent/HK1016508A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU586860B2 (en) | Therapeutical application of phosphonylmethoxyalkyl adenines | |
TW376320B (en) | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma | |
YU18899A (sh) | L-nukleozidi purina, njihovi analogoni i primena | |
MY117892A (en) | Therapeutic compounds | |
IE900073L (en) | Treatment of diseases associated with hiv infections | |
ZA968783B (en) | Flupirtine usage | |
AP9801286A0 (en) | Therapeutic compounds. | |
MY105855A (en) | Therapeutic nucleotides. | |
MD970254A (en) | Use of melatonine for treatment of patients having a medicamental dependence | |
AU2880595A (en) | Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
NZ512850A (en) | Treatment of papillomavirus infections | |
AU4111600A (en) | The use of gssg reductase for the therapy and prophylaxis of hiv infected patients | |
FR2632525B1 (fr) | Application therapeutique de la myeloperoxydase humaine | |
AU5535498A (en) | Treatment of HIV positive patients | |
WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
MX9700560A (es) | Metodo de uso de integrasa retroviral negativa transdominante en el tratamiento de infecciones retrovirales. | |
AU2396900A (en) | Treatment and prevention of hiv and other viral infections | |
AU2211592A (en) | Method of treatment for latent virus infection | |
MD1051C2 (ro) | Remediu antiherpetic | |
ES8700940A1 (es) | Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus | |
AU2450900A (en) | Therapeutic nucleoside compound | |
WO1988008707A3 (en) | Rubradirin derivatives for treatment of hiv infection | |
AU660916B2 (en) | Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours | |
GR950100315A (el) | Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος. | |
AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses |